Medtronic opens China HQ
This article was originally published in Clinica
Medtronic has established new headquarters in Shanghai, China, which will serve as a centre for its growing operations in the region. The company plans to expand its activities in China by hiring and training 1,000 new employees there in the next five years, and will also invest in R&D, clinical studies and manufacturing. The move is in stark contrast to Medtronic's plans to cut up to 2,000 jobs, announced last month when it posted modest growth in its third fiscal quarter (www.clinica.co.uk, 22 February 2011). At the time, the Minneapolis, Minnesota company had said that these cuts were more likely to come in slower-growing developed markets rather than developing economies (www.clinica.co.uk, 23 February 2011). Medtronic opened its first office in Shanghai in 1996. In 2008, the firm formed a joint venture with Weigao Group, a local leading medical device company.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.